History | Nintedanib for treating progressive fibrosing interstitial lung diseases | Guidance | NICE

History

Final draft guidance

Final draft guidance
Final appraisal document (PDF 347 KB)

Published:

18 October 2021
Committee papers (PDF 4.74 MB)

Published:

18 October 2021
Public committee slides (PDF 1.6 MB)

Published:

18 October 2021

Draft guidance

Draft guidance
Appraisal consultation document (PDF version) (PDF 369 KB)

Published:

04 August 2021
Appraisal consultation document (online commenting)
Committee papers (PDF 6.58 MB)

Published:

04 August 2021
Public committee slides (PDF 2.53 MB)

Published:

04 August 2021

Invitation to participate

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 454 KB)

Published:

05 November 2020
Equality Impact Assessment (Guidance development) (PDF 125 KB)

Published:

05 November 2020
Final scope (PDF 207 KB)

Published:

05 November 2020
Final stakeholder list (PDF 182 KB)

Published:

05 November 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope pre referral (PDF 204 KB)

Published:

26 June 2020
Draft matrix pre referral (PDF 181 KB)

Published:

26 June 2020